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Abstract
Neonicotinoids are a class of insecticides considered less toxic to humans than organo-
phosphates, carbamates, organochloride and pyrethroids. The purpose of this chapter 
was to systematize existing data in the literature on acute intoxication with neonicoti-
noids to help practitioners. Clinical manifestations vary across different human systems. 
Gastrointestinal symptoms consist of nausea, vomiting, abdominal pain and corrosive 
lesions. In the central nervous system, headaches, agitation, confusion, fasciculations, 
seizures or coma may occur, while tachycardia or bradycardia, hypertension, hypoten-
sion and palpitations occur in the cardiovascular system. Respiratory effects are dyspnea, 
aspiration pneumonia or respiratory failure. Solvents that drive the insecticide also have 
an important role in the toxic effects. There are no specific biological tests of neonicoti-
noid intoxication, and their dosing is not routinely available. Treatment is symptomatic. 
Mortality is less than 3%, well below the poisoning with anticholinesterase insecticides, 
like organophosphates and carbamates.
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1. Introduction
Poisoning with insecticides is a public health problem in many countries [1]. Organophosphates 
and carbamates are the principal cause of serious poisonings, sometimes leading to death. 
Due to the high toxicity of these compounds, new insecticides called neonicotinoids (syn-
thetic analogs of nicotine) have been created [2].
The term “neonicotinoid” was initially used by Izuru Yamamoto for imidacloprid and related 
insecticides to differentiate the new insecticidal active compounds of n-AChRs from older 
nicotine insecticides [3].
© 2017 The Author(s). Licensee InTech. This chapt r is distributed under the terms of the Creative Comm s
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Neonicotinoids are used in agriculture, horticulture and forestry to combat various pests. 
They are also used to combat fleas in domestic animals, as well as against household pests. 
After spraying, they act by direct contact with the insects, or by ingestion, when the insects 
pierce or consume the vegetative parts of plants [4]. Neonicotinoids are developed and 
continue to be launched on the market, often in the absence of direct human toxicity data. 
The human toxicity of these insecticides is often extrapolated from studies on animals, 
whose relevance is unclear. Therefore, more studies on acute intoxications with this class of 
insecticides are needed. The information resulting from these studies can contribute to the 
risk assessment and management of patients with neonicotinoid intoxications and support 
the decisions of the regulatory agencies for these substances [5]. The insecticidal activity of 
neonicotinoids results mainly from the agonist effect on the insects’ postsynaptic nicotinic 
receptors for acetylcholine. They are attached to the nicotinic receptors of the postsynaptic 
membranes from both nerve and muscle cells and thus disrupt the transmission of the ner-
vous influx into the central and peripheral nervous system. Additionally, this interaction 
with the nicotinic receptors determines their desensitization, leading to a loss of synaptic 
transmission of the nervous impulse [6, 7]. In recent years, some studies have suggested 
that neonicotinoids have a negative impact on bees near crops exposed to neonicotinoids. 
It is known that exposure to thiamethoxam may cause bees to be disoriented [8, 9]. In 
2013, the European Food Safety Agency published a report confirming that neonicotinoids 
pose a risk to bees and pollinators. For this reason, under the precautionary principle, the 
European Commission has decided to temporarily suspend the use of three neonicotinoid 
substances (imidacloprid, clothianidin and thiamethoxam) for seed treatment in the agri-
culture of all EU member States [10]. However, in some countries, based on derogations 
from the ministry, they are still used.
In a large study conducted recently in three countries in Europe (the United Kingdom, 
Germany and Hungary), the results were contradictory: in the United Kingdom and Hungary, 
neonicotinoids had a negative impact on bees, while in Germany they did not seem to have 
affected their health status [11]. The findings of another recent Canadian study, conducted in 
Ontario and Quebec, are that neonicotinoids have negative effects on bees, including a 23% 
decrease in their life span [12]. It is therefore necessary to continue the studies on this subject 
in order to reach a clear and definitive scientific conclusion. Neonicotinoid insecticides are 
considered to have low toxicity in humans because they interact much less with nicotinic 
receptors in vertebrates than in insects and penetrate less the blood-brain barrier. Provided 
that they are less toxic in humans, neonicotinoid insecticides have become increasingly used 
throughout the world. However, the ingestion of large amounts of these insecticides has been 
associated with the occurrence of severe poisoning [13].
Hence, this review was performed in order to clarify some aspects of the diagnosis and treat-
ment of poisonings with neonicotinoids, useful for practitioners who face such cases and 
maybe helping improve management of these intoxications. The physicochemical properties, 
toxicokinetics, experimental data and mechanism of action of neonicotinoids, clinical symp-
toms, diagnosis, treatment and prognosis of acute intoxication with this relatively new class 
of insecticides are discussed below.
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2. Physicochemical properties of neonicotinoids
Neonicotinoids are classified by the EPA as both Class II and Class III agents and are labeled 
with the signal word “Warning” or “Caution.” Imidacloprid, the first neonicotinoid insecticide 
discovered in 1994 in Japan, is a structural analogue of nicotine derived from N-nitroguanidine 
Figure 1. Common names and molecular structures of the neonicotinoids [14].
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and is the best sold worldwide. Currently, besides imidacloprid, the neonicotinoid family 
includes thiamethoxam, clothianidin, thiacloprid, acetamiprid, dinotefuran, nitenpyram, niti-
azine, imidaclothiz, flonicamid, sulfoxaflor and cycloxaprid, the chemical structure of which 
is shown in Figure 1 [14]. Currently, neonicotinoids are homologated in agriculture in more 
than 120 countries, being sold under various commercial names [14] (Table 1).
3. Toxicokinetics
Most human toxicity data available are about imidacloprid. Penetration through the skin (pre-
dominantly in the agricultural environment) of neonicotinoid insecticides is not quantified in 
humans. Intoxication through the respiratory tract is negligible given that these molecules are 
nonvolatile. However, there may be a secondary swallowing of the inhaled aerosol micropar-
ticles. The first prospective study conducted in Sri Lanka by Mohamed F. et al. on 68 patients 
(61 with voluntary ingestion and 7 with cutaneous exposure) showed that the mean plasma 
concentration of imidacloprid was 10.58 ng/l, IQR: 3.84–15.58 ng/l, range: 0.02–51.25 ng/l. In 
seven patients, the plasma concentration remained elevated for 10–15 h postingestion, sug-
gesting that absorption and/or elimination may be prolonged at high doses. The time-concen-
tration profiles have demonstrated a rapid initial absorption [5]. The plasma peak is reached 
within 2 h. There is no preferential distribution in fat-rich tissues [15]. In insects, mammals 
and plants, neonicotinoids undergo phase I and phase II biotransformation (Figure 2).
In vitro studies on the metabolism of neonicotinoids have indicated the importance of cyto-
chrome P450s (CYP) in their oxidation and reduction. Through a variety of human CYP iso-
enzymes, imidacloprid is oxidized to 5-hydroxyimidacloprid and imidacloprid olefin and 
reduced to nitrosoguanidine, aminoguanidine and urea imidacloprid. The most active CYP 
isoenzyme for oxidation of the imidacloprid residue is CYP 3A4 (CYP most abundant in 
humans), followed by CYP 2C19, 2A6 and 2C9. For nitroreduction, the most active CYP are: 
CYP 1A2, 2B6, 2D6 and 2E1 [16, 17].
Generation of neonicotinoids Type of neonicotinoid Physical state
First-generation neonicotinoids Imidacloprid Clear crystals or beige powder
Nitenpyram Pale yellow crystals
Acetamiprid White crystals, white fine powder, odorless
Thiacloprid Yellow crystalline powder, odorless
Second-generation neonicotinoids Thiamethoxam Slightly creamy crystalline powder, odorless
Clothianidin Clear colorless solid powder, odorless
Third-generation neonicotinoids Dinotefuran White crystalline solid, odorless
Sulfoxaflor White solid
Cycloxaprid Wettable powder
Table 1. The physical state of neonicotinoids.
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Thiamethoxam is converted to clothianidin, which is more active than the parent molecule, 
mostly by CYP 3A4 and to a lesser extent by CYP 2C19 and 2B6, and is demethylated by 2C19. 
Clothianidin is demethylated by CYP 3A4, 2C19 and 2A6 [18]. There is no accumulation of 
neonicotinoids in the body: over 90% are eliminated in less than 24 h and totally in 48 h [15, 19].
4. Experimental data and mechanisms of action
Neonicotinoids are neither irritating to eyes and skin (rabbit) nor sensitizing (guinea pigs) 
[15]. Their acute toxicity to mammals is variable depending on the type of neonicotinoid. The 
amount of toxic product that kills 50% of the experimental animals, called the lethal dose (LD 
50), is illustrated in Table 2 for the main neonicotinoids.
With an LD 50 of 425–475 mg/kg administered orally in rats, the toxicity of imidacloprid is 
mild to moderate. A single 42 mg/kg dose has no effect. After 2–6 h, poisoned animals present 
with apathy, trembling with ataxia, hypothermia and respiratory arrest [19, 20].
Neonicotinoids have been designed to be effective as insecticides by contact or ingestion 
[21]. In both insects and humans, neonicotinoids behave as postsynaptic acetylcholine 
receptor agonists, which are neurotransmitters of the central nervous system, the para-
sympathetic nervous system and some of the sympathetic system. Their irreversible link-
ages with these receptors initially stimulate, then rapidly block the Na+/K+ channels and 
inhibit the transmission of the nervous influx. Their high insect toxicity is explained by 
the predominance of nicotinic receptors in the central nervous system of these species, by 
Figure 2. Sites of metabolite attack on IMI and 6-chloronicotinic acid (CNA) for phase I and phase II reactions [16].
Common name Local effects Rat oral LD50 Rabbit dermal LD50
Acetamiprid Absent 450 >2000
Clothianidin Absent >5000 >2000
Dinotefuran Absent 2000 >2000
Imidacloprid Absent 4870 >2000
Thiamethoxam Absent >5000 >2000
Table 2. Neonicotinoid pesticides mammalian toxicities (mg/kg of body weight) [7].
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the absence of the blood-brain barrier and by their affinity for some insect-specific recep-
tor subtypes, in particular α4β2 [19]. In mammals, the predominant receptor subtype is 
α4p2, which is found to have the highest density in the thalamus. In the developing brain, 
this subtype is involved in proliferation, apoptosis, migration, differentiation, synapse 
formation and neuronal circuits [22]. Given that in mammals nicotinic receptors have a 
wider distribution (neuromuscular junction), the neonicotinoid affinity for these receptors 
is lower and the central action is reduced because of poor intracerebral penetration [17]. 
The toxicity of imidacloprid is very low in dermal exposure and is moderate in case of 
ingestion. In case of inhalation, the toxicity is variable: as dust it is considered to be slightly 
toxic, but as aerosols it is very toxic [23].
5. Epidemiology of acute poisoning with neonicotinoids in humans
Despite the widespread use of neonicotinoids, there are few reports in the literature on 
human toxicity. The first case report was made in 2001 by Wu IW et al. Clinical manifes-
tation included drowsiness, disorientation, dizziness, oral and gastroesophageal erosions, 
hemorrhagic gastritis, productive cough, fever, leukocytosis and hyperglycemia. The patient 
recovered without complications with supportive treatment and was discharged 4 days after 
ingestion [24]. Most cases were reported in USA (Texas), France, China and Sri Lanka [25, 
26, 13]. The epidemiological aspects resulting from these studies are summarized in Table 3.
Studies Cohort of the study Country of study Epidemiological findings
Forrester M et al., 
2014 [25]
1142 cases of acute 
intoxication reported by Texas 
Intoxication Control Centers 
over the period 2000–2012 
(retrospective study)
USA • 77% with imidacloprid
• 17% with dinotefuran
• 64% female
• 32 serious cases (2.9%)
• Intoxication mode: ingestion (51%), 
cutaneous (44%) and ocular (11%)
• 28% children aged <5 years and 9% 
aged 6–19 years
• 97% accidental
Boels D, 
Chataigner D, 
2014 [26]
482 cases of acute poisoning 
with imidacloprid between 
January 1999 and December 
2012 (retrospective study)
France • Increase from 8 cases in 1999 to 34 
cases in 2012
• 120 cases (28%) were children <5 years
• 37 cases (8.6%) children aged 
5–14 years
• 389 poisonings were accidental, 24 
voluntary, and in 15 cases it was not 
possible to specify the circumstances 
of intoxication
• Seven cases were serious, requiring 
intensive care
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The prevalence of voluntary intoxication was different from one study to another: only 2% in 
the study in Texas and 4.9% in the study in France, as opposed to the studies in China and Sri 
Lanka, where 81% and 82%, respectively, were classified as an attempt of suicide [25, 26, 13].
There are also differences in childhood poisoning frequency: in the study conducted in Texas, 
37% were patients under the age of 19, and in France 36.6% were children under the age of 14, 
whereas the study in China recorded only two children with accidental poisoning. The study 
in Sri Lanka does not specify the age of the patients.
Regarding the manner of intoxication, in the US study only 51% of poisoning occurred 
through ingestion, compared to 91% (61/68 cases) in Sri Lanka and 81% (57/70) in China.
In addition to these studies, several sporadic cases have been reported. Thus, eight cases were 
reported in India [27–33], two in Turkey [34, 35], two in Portugal [36], two in Colombia [37], 
two in Japan [38], one case in Saudi Arabia [39], Iran [40], Poland [41] and four cases in Taiwan 
[41–45].
6. Clinical symptoms of poisoning by neonicotinoids
Symptoms of neonicotinoid poisoning appear to be less severe in humans than in insects, 
because their affinity for human nicotinic receptors is lower and they do not cross the blood-
brain barrier. Clinical picture is better known for intoxication with imidacloprid, which is 
the oldest neonicotinoid used as an insecticide. A large study conducted in Texas between 
2000 and 2012 on 1142 patients with neonicotinoid exposure found that the main symp-
toms are: eye irritation and dermatitis, nausea, vomiting, corrosive oral mucosal lesions, 
Studies Cohort of the study Country of study Epidemiological findings
Phua DH et al, 
2009 [13]
70 cases of acute intoxication 
reported by the Taiwan 
National Poison Center 
between 1987 and 2007 
(retrospective study)
China • Dramatic increase in the number of 
cases between 2003 and 2007: 58 cases 
out of the total of 70
• Two children with accidental 
poisoning
• 67 males
• 48 cases were suicidal attempts, of 
which eight consumed ethanol
• Toxic: imidacloprid (64 cases), acet-
amiprid (4) and clothianidin (2).
• Two deaths (mortality rate 2.9%)
Mohamed F 
et al., 2009 [5]
68 cases of acute poisoning 
with imidacloprid between 
March 2002 and March 2007 
(prospective study)
Sri Lanka
The dosing was 
done in laboratories 
in Australia
• 61 out of 68 patients (91%) were intoxi-
cated by ingestion
• 82% were voluntary poisonings
Table 3. The main epidemiological aspects of neonicotinoid intoxication studies.
Acute Poisoning with Neonicotinoid Insecticide
http://dx.doi.org/10.5772/intechopen.72004
113
Symptomatology Benign forms
Minor, mild symptoms that 
spontaneously regress
Moderate forms
Pronounced or prolonged symptoms or signs
Severe forms
Severe symptoms that threaten vital prognosis
Neurological • Sleepiness, vertigo, ataxia, tinnitus
• Glasgow score 12–14
• Slight agitation
• Minor extrapyramidal symptoms
• Minor cholinergic/anticholinergic 
symptoms
• Paresthesia
• Minor visual and hearing 
impairments
• Disturbances of consciousness with delayed 
response to pain
• Glasgow score 8–11
• Apnea, bradypnea
• Confusion, agitation, hallucinations, delirium
• Localized or generalized seizures (rarely)
• Marked extrapyramidal symptoms
• Noticeable cholinergic/anticholinergic 
symptoms
• Isolated paralysis without affecting vital 
functions
• Visual and auditory disturbances
• Deep coma with inappropriate or absent 
response to pain
• Glasgow score 3–7
• Depression or respiratory failure
• Extreme agitation
• Generalized seizures
• Convulsive state, opisthotonus
• Generalized paralysis or paralysis that affects 
vital functions
• Blindness, deafness
Eye • Irritation, conjunctival hyperemia, 
tears
• Minor eyelid edema
• Marked irritation
• Limited, circumscribed corneal involvement
• Punctual keratitis
• Corneal ulcer
• Corneal perforations
• Definitive sequelae
Skin • Irritation, first-degree burns
• Second-degree burns and <10% body 
surface area (BSA)
• Second-degree burns with 10–50% BSA to adult 
and 10–30% BSA to child
• Third-degree marks <2% BSA
• Second-degree burns >50% BSA to adult and 
>30% BSA to child
• Third-degree burns >2% BSA
Bites/stinging • Edema, localized pruritus
• Discrete pain
• Localized edema involving the entire member
• Localized necrosis
• Moderate pain
• Extensive edema comprising the adjacent 
member and the adjacent parts
• Critical location of edema with danger to the 
integrity of the upper airways
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Symptomatology Benign forms
Minor, mild symptoms that 
spontaneously regress
Moderate forms
Pronounced or prolonged symptoms or signs
Severe forms
Severe symptoms that threaten vital prognosis
Muscle • Slight or moderate pain
• Sensitivity to palpation
• Rhabdomyolysis
• CPK: 250–1500 ui/l
• Pain, stiffness, cramps
• Fasciculations
• Rhabdomyolysis
• CPK: 1500–10,000 ui/l
• Intense pain, extreme rigidity
• Extensive cramps
• Extended, diffuse fasciculations
• Rhabdomyolysis with complications
• CPK > 10,000 ui/l
• Compartment syndrome
Kidney • Proteinuria and/or minimal 
hematuria
• Proteinuria and/or massive hematuria
• Oliguria, polyuria
• Serum creatinine: 200–500 mmol/l
• Kidney failure, anuria
• Serum creatinine >500 μmol/l
Blood • Minor hemolysis
• Methemoglobinemia ranging from 
10 to 30%
• Hemolysis
• Methemoglobinemia ranging from 30 to 50%
• Coagulation disorders without bleeding
• Anemia, leukopenia, thrombocytopenia
• Massive hemolysis
• Methemoglobinemia >50%
• Coagulation disorders with bleeding
• Anemia, leukopenia, severe 
thrombocytopenia
Liver • ASAT, ALT: 2–5 times normal • ASAT, ALAT: 5–50 times normal
• Without obvious clinical signs of liver 
dysfunction
• ASAT, ALT >50 times normal
• Affecting clotting factors
• Clinical signs of liver failure
Table 4. The symptomatology of imidacloprid poisoning depending on severity [26].
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dizziness, hypertension and tachycardia [25]. The French Toxicity Co-ordination Committee 
analyzed 428 cases of exposure to imidacloprid between 1999 and 2012, of which over 27% 
were children under 5 years of age. As a result of this study, the symptomatology was better 
outlined according to the severity of the intoxication (mild, moderate or severe), as illus-
trated in Table 4 [26].
There was reported a case with concomitant intoxication with imidacloprid and alcohol inges-
tion, resulting in multiple organ failure [45]. Another case was reported by Agarwal and 
Srinivas, manifesting severe neuropsychiatric disorders and rhabdomyolysis [31]. In Colombia, 
Estrada et al. signaled two cases admitted with digestive manifestations, coma (Glasgow score 
6 and 3, respectively) and respiratory failure with 70–75% Sa O
2
. One of the patients also pre-
sented dormant miosis and was thus given atropine [37]. In Saudi Arabia, there was a case 
with generalized erythematous maculopapular rash typical of leukoclastic vasculitis, which 
was confirmed by biopsy. It also associated hepatic and renal dysfunction, requiring dialysis 
[40]. Another case reported in Taiwan presented fatal ventricular fibrillation [45].
The main symptoms of acetamiprid poisoning are severe nausea, vomiting, muscle weakness, 
hypothermia and convulsions [46]. Clinical manifestations include tachycardia, hypotension, 
electrocardiogram changes, hypoxia and thirst in the case of the highest serum concentra-
tion of acetamiprid. The symptoms were partly similar to acute organophosphate intoxica-
tion [30]. In one case, ventricular fibrillation that lasted 11 h after ingestion was described 
[45]. Similar to imidacloprid poisonings, there was reported a case of severe multiple organic 
dysfunction [43]. Another case of acetamiprid intoxication was by suicidal ingestion, where 
symptoms included prolonged muscle weakness, similar to the intermediate syndrome in 
organophosphorus intoxication. The case resolved in about 3 weeks [35].
Symptoms of thiamethoxam intoxication are less known, and cases are rarely reported. Vinod 
et al. noted a case manifesting nausea, vomiting, agitation and multiple episodes of general-
ized tonic-clonic seizures within the first 2 h of ingestion of thiamethoxam. Subsequently, 
coma, hypotension, renal failure, metabolic acidosis and rhabdomyolysis occurred, with fatal 
outcome 36 h after ingestion [29].
Solvents used in neonicotinoid insecticide solutions can also play an important part in poison-
ing symptoms. Although not all solvents contained by neonicotinoid insecticides are known, 
most of them use N-methylpyrrolidone. Ingestion of a large amount of this substance irritates 
the upper gastrointestinal tract and causes oral ulceration, nausea, vomiting, dysphagia, ody-
nophagia and abdominal pain [24].
7. Diagnosis of poisoning incidents
The diagnosis is based on anamnesis and clinical symptoms. There are no specific abnor-
malities of acute poisoning with neonicotinoids [5]. There may be metabolic disturbances 
(Table 5). Dosage of neonicotinoids is not routinely available, its interest being purely 
medicolegal. Depending on the symptomatology of each case, additional investigations 
may be necessary.
Poisoning - From Specific Toxic Agents to Novel Rapid and Simplified Techniques for Analysis116
Depending on the intensity and duration of cardiovascular, respiratory and digestive symp-
toms, three degrees of severity can be distinguished (Table 6):
1. Benign: mild symptoms that spontaneously regress;
2. Moderate: pronounced or prolonged symptoms/signs;
3. Severe: severe symptoms that may influence the vital prognosis.
Clinical forms Mild Moderate Severe
Acidobasic 
disorders
• HCO
3
: 15–20 or 
30–40 mmol/l
• pH: 7.25–7.32 or 7.50–7.59
• HCO
3
: 10–14 
sau > 40 mmol/l
• pH: 7.16–7.24 sau 
7.60–7.69
• HCO
3
 < 10 mmol/l
• pH < 7.15 or >7.7
Electrolytic 
disorders
• K: 3–3.4 or 5.2–5.9 mmol/l
• Moderate hypoglycemia: 
0.5–0.7 g/l or 2.8–3.9 mmol/l
• Short-term hyperthermia
• K: 2.5–2.9 or 
6–6.9 mmol/l
• Severe hypoglyce-
mia: 0.3–0.5 g/l or 
1.7–2.8 mmol/l
• Prolonged 
hyperthermia
• K: <2.5 or >7 mmol/l
• Severe hypoglycemia <0.3 g/l 
or <1.7 mmol/l
• Malignant hyperthermia/
hypothermia
Table 5. Metabolic disorders depending on the severity of intoxication [26].
Forms Cardiovascular symptoms Respiratory symptoms Digestive symptoms
Benign • Isolated extrasystoles
• Discrete, transient hypotension
• Transient, discrete hypertension
• Airways irritation
• Coughing, breathlessness
• Slight dyspnea
• Slight bronchospasm
• Abnormal thoracic radiogra-
phy with or without minor 
symptoms
• Vomiting
• Diarrhea
• Abdominal pain
• Minor oral ulceration
• Endoscopy: erythema, 
stage I edema
Moderate • Sinus bradycardia:
 ○ Adults 40–50 b/min
 ○ Children 60–80 b/min
 ○ New born 80–90 b/min
• Frequent premature beats
• Atrial flutter/fibrillation
• AVB grade I or II
• Prolonged QRS and QTc
• Repolarization modifications
• Myocardial ischemia
• Hypo/hypertension
• Prolonged cough
• Stridor, bronchospasm
• Dyspnea
• Hypoxia requiring oxygen 
administration
• Abnormal pulmonary 
radiography with moderate 
symptoms
• Pronounced or prolonged 
vomiting
• Diarrhea
• Abdominal pain
• First-grade burns of a 
critical area or II and III 
grade burns on limited 
areas
• Dysphagia
• Endoscopy: stage IIa tran-
sient ulcerative lesions
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Differential diagnosis should take into account intoxications with other pesticides. This poi-
sonings can mimic light forms of organophosphorus or carbamates intoxications. Also, many 
cases reported involved combinations of multiple pesticides and ethanol [5, 13].
8. Management of poisoning incidents
Management of acute neonicotinoid insecticide poisoning is mainly symptomatic and sup-
portive. Dermal and mucosal exposures should be decontaminated as soon as possible [13].
In case of coma and respiratory distress, intubation and assisted ventilation associated with 
hemodynamic support are required. The presence of solvents in liquid neonicotinoid formulas 
makes the activated charcoal and gastric lavage or vomiting ineffective, due to the risk of inhala-
tion pneumonia [13]. Gastric lavage and activated charcoal should be avoided if corrosive injuries 
of the oral and gastrointestinal mucosa are found. Activated charcoal may hinder endoscopic 
evaluation of patients with corrosive lesions [13]. Prudent aspiration of the gastric contents can 
be considered, with respiratory protection, and if the ingested volume is high (over 100 ml), the 
ingestion period is short (less than 1 h) [13, 15]. The respiratory effects of neonicotinoids should 
be carefully monitored, particularly hypoventilation and respiratory failure. Patients with upper 
airway injuries such as hoarseness and stridor caused by irritant and corrosive effects of the sol-
vent should probably undergo endoscopic assessment of vocal cordons [13].
Forms Cardiovascular symptoms Respiratory symptoms Digestive symptoms
Severe • Severe sinus bradycardia:
 ○ Adults <40 b/min
 ○ Children <60 b/min
 ○ New born <80 b/min
• Severe sinus tachycardia
 ○ Adults >180 b/min
 ○ Children >190 b/min
 ○ New born >200 b/min
• Ventricular dysrhythmia with 
vital prognosis
• AVB grade III
• Asystole
• Myocardial infarction
• Shock
• Malignant hypertensive 
disorder
• Respiratory failure: severe 
bronchospasm, dyspnea, 
airway obstruction, ARDS, 
pulmonary edema, glottis 
edema, bronchopneumonia, 
pneumopathy, pneumothorax
• Abnormal pulmonary radiog-
raphy with severe symptoms
• Severe digestive 
hemorrhage
• Digestive perforation
• Enlarged II and III grade 
burns
• Severe dysphagia
• Endoscopy: transmural 
ulcer lesions, circumfer-
ential lesions, perfora-
tions stage IIB, III and IV
Table 6. Degrees of severity according to intensity and duration of cardiovascular, respiratory and digestive symptoms 
[26].
Poisoning - From Specific Toxic Agents to Novel Rapid and Simplified Techniques for Analysis118
Sometimes, organophosphorus intoxication may also be associated. In this case, acute 
poisoning may be manifested by miosis, bradycardia, hypersalivation and bronchorrhea. 
Because of these symptoms, atropine and oximes may be improperly used as an antidote. 
It is unknown whether these drugs are effective or may worsen the outcome of neoni-
cotoid insecticide poisonings. In cases with life-threatening muscarinic manifestations (e.g., 
bronchorrhea with airway compromise), the use of atropine may be justified in neonicot-
inoid-poisoned patients [13, 44]. Oximes (e.g., pralidoxime) are usually either ineffective 
or contraindicated. In the absence of organophosphorus pesticides, oximes have a weak 
inhibitory effect on acetylcholinesterase activity and therefore may increase nicotinic effects 
(tachycardia, hypertension and muscle weakness) [5]. Because the severity of poisoning is 
not proportional to the plasma concentration of neonicotinoids, hemofiltration is ineffective 
in increasing their elimination [13, 43].
9. Prognosis and comparative mortality rates
The numbers of neonicotinoid poisonings have increased in the last decade, given that neo-
nicotinoid insecticide is highly used. Respiratory, cardiovascular and certain neurological 
presentations (dyspnea/apnea, coma, tachycardia, hypotension, mydriasis and bradycar-
dia) are symptoms of severe neonicotinoid intoxication [43]. Biochemical abnormalities and 
rhabdomyolysis have been reported as potentially serious complications that might lead to 
mortality [5].
Mortality through imidacloprid poisoning ranges from 0% to 4.2% in various studies. In a 
study in Taiwan, neonicotinoid poisoning mortality was 2.9%, inferior to that with organo-
phosphates (12.3%) or carbamates (7.3%), but close to that with synthetic pyrethroids (3.1%) 
[47]. In the study in France conducted on 428 patients with acute neonicotinoid poisoning, six 
deaths were recorded [26]. Another study in Korea on 24 cases shows a mortality rate of 4.2% 
[48]. In addition to these studies on larger cohorts of patients, sporadic cases of acute neonic-
otinoid poisoning deaths are also reported in the literature (Table 7).
Authors, year of the study Place of study The type of neonicotinoid Death numbers
Proença P et al., 2005 [36] Portugal Imidacloprid 2
Huang NC et al.,2006 [45] Taiwan Imidacloprid 1
Shadnia S et al., 2008 [40] Iran Imidacloprid 1
Yeh IJ et al., 2010 [44] China Imidacloprid 1
Iyyodurai R et al., 2010 [30] India Imidacloprid 1
Harish J et al., 2011 [49] India Imidacloprid 1
Fuke C et al., 2014 [49] Japan Imidacloprid 1
Vinod KV et al., 2015 [29] India Thiacloprid 1
Table 7. Deaths by acute poisoning with neonicotinoids reported in the literature.
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10. Concluding remarks
Neonicotinoids act quite selectively on insects, but they are not free of human toxicity. Several 
cases of acute intoxication with such insecticides, sometimes severe, resulting in death, have 
been reported in the literature. The above review has highlighted the consequences of poisoning 
with these newer pesticides, not very well known at the moment. Therefore such information 
is valuable for clinicians, regulatory authorities and the public at large. Given the fact that these 
insecticides are increasingly being used in agriculture, horticulture and fish farming, but also for 
combating domestic pests, more studies on the human health effects of neonicotinoids exposure 
are needed and maybe some awareness programs about its toxicity should be implemented.
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